20 mg/ml of CBD + 1 mg/ml of THC + Olive OilBenefits of product:
• The high CBD factor in this strain makes CanniMed 1:20 oil stand out among the company’s other edible products. While the
strain does help calm nerves an enhance mood, the low THC reduces its ability as a sedative and analgesic. At the same time,
however, CBD brings a set of unique benefits catered toward a specific group of people.
• As a relaxant, CanniMed 1:20 Oil offers relief from milld to moderate anxiety, stress, insomnia, ADD, ADHD and PTSD.
Meanwhile, the uplifting nature helps patients with depression and fatigue.
• CanniMed 1:20 Oil is fairly effective analgesic due to its incredibly high CBD levels. Patients report that it helps with neck pain,
back pain, joint pain, muscle pain, arthritis, inflammation and fibromyalgia.
• CBD has its own range of unique benefits as well. It has recently been found to be a cancer-inhibitor and is often prescribed to
treat severe epilepsy.
No terpene profile is available for CanniMed 1:20 Oil.Additional Ingredients:
All of CanniMed’s oils use olive oil as their carrying agent.
CanniMed irradiates all of its dry herb. Irradiation is a highly effective way to ensure that products are:
• Without yeast or fungus
• Free of harmful bacteria
CanniMed also uses pesticide-free growing methods and tests for toxins, heavy metals and other hazardous substances.
• Dry eyes
• Dry mouth
All of CanniMed’s strains are hybrids. Aside from this, no other information is available due to their proprietary nature.
CanniMed applies a careful extraction process for its oils. They use pharmaceutical grade ethanol (grain alcohol) as a solvent to extract the cannabinoids from their dry herb. They carefully ensure that no stems, seeds or other waste makes it into the mixture. Once complete, CanniMed infuses the cannabinoids in olive oil – one of the most nutritious carriers available.
After processing and extraction, third-party testing confirms that excess solvents are either gone or well below acceptable levels.
While not as clean as the advanced (and expensive) CO2 extraction process employed by some companies, this is still a safe and reliable method, especially since third party tests are part of the process.
CanniMed rigorously works to meet Good Manufacturing Practices (GMP), as outlined by Canadian pharmaceutical laws and regulations.
Established in 2013, CanniMed is one of the most experienced medical licensed producers. While the CanniMed name was around since 2013, its parent company opened in 2000. Known as Prairie Plant Systems, this organization was single-handedly responsible for supplying medical cannabis to Health Canada from 2000 – 2013.
CanniMed is also heavily research-focused. Running various clinical trials, they provide valuable research into cannabis’ benefits for those with Tourette’s, juvenile epilepsy and chronic pain. Their products have also been directly used in various clinical trials and studies.